Diabetic kidney disease (DKD) is a serious complication of type-2 diabetes, defined prominently by a reduction in estimated glomerular filtration rate (eGFR), a measure of renal waste excretion capacity. However DKD patients present high heterogeneity in disease trajectory and response to treatment, making the one-model-fits-all pro- tocol for estimating prognosis and expected response to therapy as proposed by guidelines obsolete. As a solution, precision or stratified medicine aims to define subgroups of patients with similar pathophysi- ology and response to the therapy, allowing to select the best drug com- binations for each subgroup. We focus on eGFR when aiming to identify eGFR decline trends by clustering patients according to their eGFR tra- jectory shape-similarity. The study involved 256 DKD patients observed annually for four years. Using the Fr ́echet distance, we built clusters of patients according to the similarity of their eGFR trajectories to identify distinct clusters. We formalized the trajectory-clustering approach through category the- ory. Characteristics of patients within different progression clusters were compared at the baseline and over time. We identified five clusters of eGFR progression over time. We noticed a bifurcation of eGFR mean trajectories and a switch between two other mean trajectories. This particular clustering approach identified different mean eGFR trajectories. Our findings suggest the existence of distinct dynamical behaviors in the disease progression.
Distefano, V., Mannone, M., Poli, I., Mayer, G. (2024). Clustering Trajectories to Study Diabetic Kidney Disease. In Artificial Life and Evolutionary Computation. WIVACE 2023 (pp. 271-283) [10.1007/978-3-031-57430-6_21].
Clustering Trajectories to Study Diabetic Kidney Disease
Mannone, Maria
;
2024-03-30
Abstract
Diabetic kidney disease (DKD) is a serious complication of type-2 diabetes, defined prominently by a reduction in estimated glomerular filtration rate (eGFR), a measure of renal waste excretion capacity. However DKD patients present high heterogeneity in disease trajectory and response to treatment, making the one-model-fits-all pro- tocol for estimating prognosis and expected response to therapy as proposed by guidelines obsolete. As a solution, precision or stratified medicine aims to define subgroups of patients with similar pathophysi- ology and response to the therapy, allowing to select the best drug com- binations for each subgroup. We focus on eGFR when aiming to identify eGFR decline trends by clustering patients according to their eGFR tra- jectory shape-similarity. The study involved 256 DKD patients observed annually for four years. Using the Fr ́echet distance, we built clusters of patients according to the similarity of their eGFR trajectories to identify distinct clusters. We formalized the trajectory-clustering approach through category the- ory. Characteristics of patients within different progression clusters were compared at the baseline and over time. We identified five clusters of eGFR progression over time. We noticed a bifurcation of eGFR mean trajectories and a switch between two other mean trajectories. This particular clustering approach identified different mean eGFR trajectories. Our findings suggest the existence of distinct dynamical behaviors in the disease progression.File | Dimensione | Formato | |
---|---|---|---|
wivace_trajectories.pdf
accesso aperto
Tipologia:
Versione Editoriale
Dimensione
929.08 kB
Formato
Adobe PDF
|
929.08 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.